Centre leader Mamelund has been interviewed about our ongoing CAS-project: Why did he become interested in pandemic studies? What is our project about? What have we done so far? And why is curiosity-driven research important and CAS so good for our project?
We are proud to announce that one of our earlier masters’ students just published a paper in BMC Public Health.
Results show that vaccine hesitancy was low overall (5.8%). Findings indicate that participants with younger ages, lower education, and lower household income, and those born outside of Norway were prone to vaccine hesitancy. Over half of the vaccine hesitant sample cited barriers relating to confidence in the vaccines. Women and participants born in Norway were more likely hesitant due to fear of side effects and there being little experience with the vaccines. Otherwise, complacency barriers such as not feeling that they belonged to a risk group (46.1%), not needing the vaccines (39.1%), and wanting the body to develop natural immunity (29.3%) were frequently selected by participants.
On 6 October at 1600 CET, Alexi Gugushvili, University of Oslo, will present “The COVID-19 Pandemic and War: The Case of Ukraine.”
The COVID-19 pandemic may change the dynamics of existing conflicts or may create conditions for violence through heightened nationalism, xenophobia, or economic hardship. Eastern Europe has been one of the hot spots of the pandemic, and it is currently a location of the most intense interstate armed conflict since the Second World War. In this talk, I will outline possible channels linking pandemics and heightened probability for armed conflict occurrence. I will also describe the COVID-related developments in Russia and Ukraine which preceded president Putin’s decision on the full-scale invasion of Ukraine on February 24, 2022.